Trader’s Buzz: TG Therapeutics (TGTX), Calithera Biosciences (CALA), Ciena Corporation (CIEN), Sangamo Biosciences (SGMO), Lululemon (LULU)
December 11, 2014 at 13:25 PM EST
In a report issued to clients Thursday, ROTH Capital raised its price target for TG Therapeutics, Inc. (TGTX) to $33 from $25. ROTH said it boosted its 12-month base case estimate on company’s strong ASH showing and buyout prospects. The equity firm maintains a Buy/Focus pick. TG Therapeutics, Inc., currently valued at $765.41M, has a […] View the full post at: Trader’s Buzz: TG Therapeutics (TGTX), Calithera Biosciences (CALA), Ciena Corporation (CIEN), Sangamo Biosciences (SGMO), Lululemon (LULU) Related posts: SEC proposes identification for fast traders